Evidence map›Paper›PMID 39585331›Full record

ArticleACS biomaterials science & engineering2024

Engineering Granular Hydrogels without Interparticle Cross-Linking to Support Multicellular Organization.

Natasha L Claxton, Melissa A Luse, Brant E Isakson, Christopher B Highley

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Biomaterials in organoid research: current state and future directions.Frontiers in bioengineering and biotechnology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natasha L ClaxtonDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22903, United States.ORCID 0000-0002-0750-8224
Melissa A LuseDepartment of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, Virginia 22903, United States.
Brant E IsaksonDepartment of Molecular Physiology and Biophysics, University of Virginia School of Medicine, Charlottesville, Virginia 22903, United States.
Christopher B HighleyDepartment of Biomedical Engineering, University of Virginia, Charlottesville, Virginia 22903, United States.ORCID 0000-0001-9153-4013

Funding

Purinergic Regulation of Veinous Endothelial PermeabilityR01HL137112 · NHLBI · UNIVERSITY OF VIRGINIA · PI Brant E Isakson, MICHAEL H. KOVAL · 2018 to 2026
$4.7M
Biotechnology Training ProgramT32GM136615 · NIGMS · UNIVERSITY OF VIRGINIA · PI Silvia Salinas Blemker, Kimberly A. Kelly · 2020 to 2026
$3.4M
Panx1-PIEZO1 Interactions Regulate Renin ReleaseR01HL171997 · NHLBI · UNIVERSITY OF VIRGINIA · PI Brant E Isakson · 2024 to 2026
$2.0M
Building biophysical and biochemical complexity in 3D cell and tissue constructsR35GM147410 · NIGMS · UNIVERSITY OF VIRGINIA · PI Christopher B Highley · 2022 to 2026
$1.9M
NHLBI NIH HHS R01 HL137112NHLBI NIH HHS R01 HL171997NIGMS NIH HHS R35 GM147410NIGMS NIH HHS T32 GM136615
6 · The paper itself

Abstract

Advancing three-dimensional (3D) tissue constructs is central to creating

Indexed as

HydrogelsPolyethylene GlycolsTissue EngineeringAnimalsCell AdhesionCoculture TechniquesCross-Linking ReagentsFibroblastsHumansHuman Umbilical Vein Endothelial CellsMiceOligopeptidesPorosityarginyl-glycyl-aspartic acidCross-Linking ReagentsHydrogelsOligopeptidesPolyethylene Glycolscellular connectivityendothelial cellsfibroblastsgranular hydrogelsmicrogelsmorphogenesispermissiveness

Identifiers

PMID39585331
PMCPMC11632665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.